ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 130 filers reported holding ARCUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $660,000 | +26.9% | 18,939 | 0.0% | 0.23% | +29.1% |
| Q2 2021 | $520,000 | -2.3% | 18,939 | 0.0% | 0.18% | -9.6% |
| Q1 2021 | $532,000 | +63.7% | 18,939 | 0.0% | 0.20% | +32.0% |
| Q3 2020 | $325,000 | +23.6% | 18,939 | 0.0% | 0.15% | -0.7% |
| Q1 2020 | $263,000 | +37.7% | 18,939 | 0.0% | 0.15% | +93.6% |
| Q4 2019 | $191,000 | +11.0% | 18,939 | 0.0% | 0.08% | 0.0% |
| Q3 2019 | $172,000 | +13.9% | 18,939 | 0.0% | 0.08% | +9.9% |
| Q2 2019 | $151,000 | -26.0% | 18,939 | 0.0% | 0.07% | -34.9% |
| Q4 2018 | $204,000 | – | 18,939 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |